Sacubitril/Valsartan — Dosing in CKD & Dialysis

Sacubitril/Valsartan (ARNI): renal dosing adjustments, dialyzability (Unlikely to be removed by hemodialysis (high protein binding, per the label)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.